Recently, biomarkers such as N-terminal pro-B-type natriuretic peptide, C-reactive protein, fibroblast growth factor-23, and high-sensitivity troponin I have been shown to be associated with AF and found to improve risk prediction [41]. This evidence concerns the gene CRP and atrial fibrillation.